Get the Stockscreener App
2.77
7.36%
-0.22
After Hours:
2.79
0.02
+0.72%
Humacyte Inc Stock (HUMA) Forecast
The Humacyte Inc (HUMA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.1832, representing a +14.92% increase from the current price of $2.77. The highest analyst price target is $3.2456, and the lowest is $3.1207.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HUMA Price Target
Average 2.1721
(-21.58% Downside)
Is Humacyte Inc (HUMA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.52 | Neutral |
| STOCH(9,6) | 11.91 | Buy |
| STOCHRSI(14) | 65.75 | Neutral |
| MACD(12,26) | -0.3346 | Sell |
| ADX(14) | 25.51 | Sell |
| William %R | -98.32 | Buy |
| CCI(14) | -51.08 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.0515
Sell
|
3.0574
Sell
|
| MA20 |
3.3158
Sell
|
3.3108
Sell
|
| MA50 |
4.0503
Sell
|
3.8313
Sell
|
| MA100 |
4.4222
Sell
|
4.3245
Sell
|
| MA200 |
5.4443
Sell
|
4.4837
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, HUMA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on HUMA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.52 indicates that HUMA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.91 indicates that HUMA is oversold. This indicates that HUMA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 65.75 indicates that HUMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.51 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -51.08 indicates that HUMA is still oversold but not to an extreme extent.
Long-term HUMA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Humacyte Inc financial reports and earnings history, Humacyte Inc (HUMA) stock could reach $4.3258 by 2030, $35.15 by 2040 and $44.87 by 2050. See the projected annual prices until 2050 of the Humacyte Inc stock below:
- Humacyte Inc (HUMA) is expected to reach an average price of $17.66 in 2035, with a high prediction of $17.91 and a low estimate of $17.93. This indicates an $537.50% rise from the last recorded price of $2.77.
- Humacyte Inc (HUMA) stock is projected to chart a bullish course in 2040, with an average price target of $34.72, representing an $1,153% surge from its current level. The forecast ranges from a conservative $34.87 to a sky-high $35.15.
- Our analysts predict Humacyte Inc (HUMA) to jump 670.37% by 2045, soaring from $21.56 to an average price of $21.34, potentially reaching $21.92. While $21.56 is the low estimate, the potential upside is significant.
- Humacyte Inc (HUMA) stock is expected to climb by 2050, reaching an average of $44.20, a $1,496% jump from its current level. However, a wide range of estimates exists, with high and low targets of $44.87 and $44.38, respectively, highlighting the market's uncertainty.
Humacyte Inc Stock (HUMA) Year by Year Forecast
Humacyte Inc Stock (HUMA) Price Forecast for 2025
Humacyte Inc Stock (HUMA) is expected to reach an average price of $1.6508 in 2025, with a high prediction of $3.288 and a low estimate of $0.0136. This indicates an -40.41% fall from the last recorded price of $2.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $2.9507 | $3.1207 | $3.2456 | +6.52% |
| May, 2025 | $2.1059 | $1.9895 | $2.817 | -23.97% |
| June, 2025 | $2.2111 | $2.2548 | $2.0022 | -20.18% |
| July, 2025 | $2.6525 | $2.7573 | $2.6862 | -4.24% |
| August, 2025 | $2.6477 | $2.5751 | $2.3601 | -4.42% |
| September, 2025 | $2.5728 | $2.6928 | $2.5539 | -7.12% |
| October, 2025 | $3.3043 | $2.8741 | $3.288 | +19.29% |
| November, 2025 | $2.7894 | $2.8594 | $2.9605 | +0.70% |
| December, 2025 | $2.1909 | $2.3709 | $2.1183 | -20.91% |
Humacyte Inc Stock (HUMA) Price Forecast for 2026
The predicted value for Humacyte Inc (HUMA) in 2026 is set at an average of $1.2521. Estimates vary from a peak of $2.1147 to a trough of $0.3895, indicating an -54.80% surge from the present price of $2.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.206 | $2.2771 | $2.1147 | -20.36% |
| February, 2026 | $1.6712 | $1.7787 | $1.8186 | -39.67% |
| March, 2026 | $0.7063 | $1.0563 | $1.5075 | -74.50% |
| April, 2026 | $1.4578 | $1.1815 | $1.0997 | -47.37% |
| May, 2026 | $1.5129 | $1.7929 | $1.6866 | -45.38% |
| June, 2026 | $1.3081 | $1.3381 | $1.4205 | -52.78% |
| July, 2026 | $0.1995 | $0.3895 | $0.8744 | -92.80% |
| August, 2026 | $1.1747 | $0.5558 | $1.0847 | -57.59% |
| September, 2026 | $1.8161 | $1.3889 | $1.7461 | -34.44% |
| October, 2026 | $1.2113 | $1.3713 | $1.5024 | -56.27% |
| November, 2026 | $0.5764 | $0.9964 | $0.9976 | -79.19% |
| December, 2026 | $0.8279 | $0.814 | $0.8279 | -70.11% |
Humacyte Inc Stock (HUMA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Humacyte Inc (HUMA) is $4.7243, with a high forecast of $9.4241 and a low forecast of $0.0245. This indicates an +70.55% increase from the last price of $2.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.267 | $0.1967 | $0.3942 | -90.36% |
| February, 2027 | $0.0118 | $0.2382 | $1.5624 | -99.57% |
| March, 2027 | $0.0196 | $0.0245 | $0.5329 | -99.29% |
| April, 2027 | $0.9952 | $0.1322 | $1.2852 | -64.07% |
| May, 2027 | $5.1352 | $1.0389 | $4.2752 | +85.38% |
| June, 2027 | $5.068 | $6.0477 | $5.9855 | +82.96% |
| July, 2027 | $4.7284 | $5.5031 | $4.8506 | +70.70% |
| August, 2027 | $7.5287 | $5.4402 | $6.1587 | +171.79% |
| September, 2027 | $10.30 | $8.1412 | $9.2616 | +271.90% |
| October, 2027 | $9.3119 | $9.3519 | $9.4241 | +236.17% |
| November, 2027 | $8.7222 | $8.9429 | $8.7944 | +214.88% |
| December, 2027 | $7.4251 | $7.2725 | $7.8948 | +168.05% |
Humacyte Inc Stock (HUMA) Price Forecast for 2028
In 2028, Humacyte Inc (HUMA) is projected to reach an average price of $8.367, with a high projection of $9.8112 and a low estimate of $6.9228. This indicates an +202.06% rise from the last price of $2.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.5254 | $6.9228 | $6.5277 | +171.67% |
| February, 2028 | $8.1057 | $8.2557 | $8.4405 | +192.62% |
| March, 2028 | $9.9886 | $8.0283 | $9.7139 | +260.60% |
| April, 2028 | $9.4839 | $9.6089 | $9.8112 | +242.38% |
| May, 2028 | $8.4018 | $8.3191 | $9.2915 | +203.31% |
| June, 2028 | $8.3721 | $8.4495 | $8.2644 | +202.24% |
| July, 2028 | $8.9024 | $8.8847 | $8.7248 | +221.39% |
| August, 2028 | $8.5053 | $8.5001 | $8.585 | +207.05% |
| September, 2028 | $8.2956 | $8.4156 | $8.3779 | +199.48% |
| October, 2028 | $9.0659 | $8.5632 | $8.8759 | +227.29% |
| November, 2028 | $8.2088 | $8.2788 | $8.7885 | +196.35% |
| December, 2028 | $7.6591 | $7.6991 | $7.4514 | +176.50% |
Humacyte Inc Stock (HUMA) Price Forecast for 2029
The 2029 price forecast for Humacyte Inc Stock (HUMA) is $5.8549 on average, with a high prediction of $7.2967 and a low estimate of $4.413. This represents an +111.37% increase from the previous price of $2.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.322 | $7.4943 | $7.2967 | +164.33% |
| February, 2029 | $6.6523 | $6.7598 | $6.8672 | +140.16% |
| March, 2029 | $5.5526 | $5.9026 | $6.4549 | +100.46% |
| April, 2029 | $5.093 | $5.893 | $5.8449 | +83.86% |
| May, 2029 | $6.0558 | $6.2955 | $6.2633 | +118.62% |
| June, 2029 | $5.7162 | $5.7462 | $5.896 | +106.36% |
| July, 2029 | $4.7165 | $4.927 | $5.2487 | +70.27% |
| August, 2029 | $5.2794 | $4.629 | $5.1894 | +90.59% |
| September, 2029 | $5.9297 | $5.4598 | $5.6547 | +114.07% |
| October, 2029 | $5.0126 | $5.1726 | $5.6822 | +80.96% |
| November, 2029 | $4.2429 | $4.6629 | $4.7651 | +53.17% |
| December, 2029 | $4.4132 | $4.413 | $4.1632 | +59.32% |
Humacyte Inc Stock (HUMA) Price Forecast for 2030
Humacyte Inc Stock (HUMA) is expected to reach an average price of $9.3592 in 2030, with a high forecast of $16.87 and a low forecast of $1.8522. This signifies an +237.88% surge from the last price of $2.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.0961 | $3.5935 | $4.3258 | +11.77% |
| February, 2030 | $3.2164 | $2.2738 | $2.9464 | +16.11% |
| March, 2030 | $3.0767 | $2.9941 | $2.9115 | +11.07% |
| April, 2030 | $1.927 | $2.617 | $2.8869 | -30.43% |
| May, 2030 | $13.22 | $1.8522 | $12.36 | +377.17% |
| June, 2030 | $14.79 | $14.10 | $13.93 | +434.05% |
| July, 2030 | $12.51 | $13.35 | $12.73 | +351.54% |
| August, 2030 | $15.17 | $13.15 | $13.80 | +447.76% |
| September, 2030 | $17.31 | $15.75 | $16.75 | +524.85% |
| October, 2030 | $16.65 | $16.69 | $16.87 | +501.18% |
| November, 2030 | $15.93 | $16.22 | $16.10 | +475.03% |
| December, 2030 | $14.06 | $14.34 | $15.07 | +407.72% |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):